Supplementary Materials from Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

Authors :: David A. Reardon
Patrick Y. Wen
Rakesh K. Jain
Alona Muzikansky
Dan G. Duda
Wendy M. Blumenschein
Qing Zhao
Jennifer H. Yearley
Mariano Severgnini
David J. Cote
Timothy R. Smith
Sarah Gaffey
Christine McCluskey
Howard Colman
Thomas Kaley
Leia Nghiemphu
John de Groot
Justin T. Jordan
Jennifer L. Clarke
Katherine Peters
Annette M. Molinaro
Lakshmi Nayak
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplemental Text

Full Text Access

Tools